Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...

Study findings suggest the therapeutic window for DAPT benefit may extend up to 42 hours, but risk increases after 72 hours.

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained ...

The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear. One month after they had undergone ...

For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

Asundexian prevented repeat strokes without bleeding side effects ...

Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...